Gaxos.AI Inc

GXAI USD0.0001 B
Create an alert
Sell$0.82
Buy$0.83
$0.03 (3.66%)
Last updated today at
Back to dashboard

Company Information

About this company

Gaxos.ai Inc. develops artificial intelligence applications designed to address opportunities across consumer, enterprise and health-related markets. The Company's operations include Gaxos Labs, which develops and commercializes AI-powered applications, and RNK Health, a majority-owned subsidiary offering personalized weight loss, longevity, and performance treatments. It also holds a strategic minority investment in America First Defense.AI, a defense-technology company developing next-generation counter-UAS and robotic platforms. Gaxos Health integrates AI-driven insights with individual biometric data and health goals to create web and application-based personalized wellness strategies for users. Gaxos Health solutions analyzes a range of health data to provide tailored wellness plans and addresses the growing demand for personalized health solutions. RNK Health is engaged in providing access to certain medications, supplements and other wellness products and services.

Key people

Vadim Mats
Chairman of the Board, Chief Executive Officer
Steven A. Shorr
Chief Financial Officer
Roman Feldman
Independent Director
Scott A. Grayson
Independent Director
Adam Holzer
Independent Director
Click to see more

Key facts

  • Shares in issue
    10.74m
  • EPIC
    GXAI
  • ISIN
    US62911P3001
  • Location
    United States
  • Sector
    Technology
  • Industry
    Software & Programming
  • Market cap
    $9.44m
  • Employees
    3
  • Exchange
    NASDAQ
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.